- Home
- CVGW vs ITOS Comparison
CVGW vs ITOS Comparison
Compare CVGW & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGW
- ITOS
- Stock Information
- Founded
- CVGW 1924
- ITOS 2011
- Country
- CVGW United States
- ITOS United States
- Employees
- CVGW N/A
- ITOS N/A
- Industry
- CVGW Specialty Foods
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVGW Consumer Discretionary
- ITOS Health Care
- Exchange
- CVGW Nasdaq
- ITOS Nasdaq
- Market Cap
- CVGW 473.8M
- ITOS 381.2M
- IPO Year
- CVGW N/A
- ITOS 2020
- Fundamental
- Price
- CVGW $26.48
- ITOS $10.11
- Analyst Decision
- CVGW Strong Buy
- ITOS Hold
- Analyst Count
- CVGW 1
- ITOS 6
- Target Price
- CVGW $35.00
- ITOS $10.60
- AVG Volume (30 Days)
- CVGW 189.5K
- ITOS 1.5M
- Earning Date
- CVGW 09-08-2025
- ITOS 08-11-2025
- Dividend Yield
- CVGW 3.02%
- ITOS N/A
- EPS Growth
- CVGW N/A
- ITOS N/A
- EPS
- CVGW 0.58
- ITOS N/A
- Revenue
- CVGW $694,486,000.00
- ITOS $35,000,000.00
- Revenue This Year
- CVGW $9.87
- ITOS N/A
- Revenue Next Year
- CVGW $4.33
- ITOS N/A
- P/E Ratio
- CVGW $45.69
- ITOS N/A
- Revenue Growth
- CVGW 12.92
- ITOS 177.89
- 52 Week Low
- CVGW $20.30
- ITOS $4.80
- 52 Week High
- CVGW $30.02
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- CVGW 49.08
- ITOS 52.39
- Support Level
- CVGW $25.65
- ITOS $10.10
- Resistance Level
- CVGW $26.89
- ITOS $10.16
- Average True Range (ATR)
- CVGW 0.57
- ITOS 0.10
- MACD
- CVGW -0.02
- ITOS -0.05
- Stochastic Oscillator
- CVGW 50.30
- ITOS 0.00
About CVGW Calavo Growers Inc.
Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The group markets and distribute avocados, prepared avocado products, and other perishable foods to retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers across the world. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.